B Hechler1,2,3,4, B Maître1,2,3,4, S Magnenat1,2,3,4, V Heim1,2,3,4, M-B El Mdawar1,2,3,4, C Gachet1,2,3,4, H de la Salle1,2,3,4. 1. UMR_S949, INSERM, Strasbourg, France. 2. Etablissement Français du Sang-Alsace (EFS-Alsace), Strasbourg, France. 3. Université de Strasbourg, Strasbourg, France. 4. Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France.
Abstract
UNLABELLED: Essentials Role of platelets in immunological transfusion-related acute lung injury (TRALI) is debated. Immunological TRALI was tested in mice exhibiting severe thrombocytopenia or platelet dysfunction. Platelets are required to prevent lung hemorrhage but not edema formation and respiratory distress. Platelets are dispensable for the initiation and development of TRALI. SUMMARY: Background Transfusion-related acute lung injury (TRALI) is a serious transfusion-related complication. Previous conflicting studies have indicated that platelets are either crucial or dispensable for TRALI. Objectives To evaluate the role of platelets in major histocompatibility complex (MHC) I-induced-TRALI. Methods Antibody-mediated TRALI was experimentally induced in mice by lipopolysaccharide priming followed by the administration of an anti-MHC I mAb. Results TRALI was tested in the context of severe thrombocytopenia provoked by the administration of diphtheria toxin (DT) in transgenic iDTR mice selectively expressing DT receptor in megakaryocytes. The pathologic responses occurring within the first 10 min following the injection of the anti-MHC I mAb, i.e. the severity of lung edema and the drop in aortic blood oxygenation, were similar in severely thrombocytopenic DT-iDTR and control mice. At later times, mortality was nevertheless increased in DT-iDTR mice, owing to lung hemorrhages. When less severe thrombocytopenia was induced with an antiplatelet mAb, TRALI started and developed similarly as in control mice, but hemorrhages were absent. Furthermore, when platelet functions were defective because of administration of aspirin or clopidogrel, or because of glycoprotein (GP)IIbIIIa deficiency, TRALI still developed but no lung hemorrhages were observed. In contrast, when GPVI was immunodepleted, TRALI still occurred, but was occasionally accompanied by hemorrhages. Conclusions Platelets are dispensable for the initiation and development of MHC I-induced TRALI. Although they do not protect against the disruption of the vascular endothelial cell barrier and the subsequent plasma leakage and edema formation, platelets are essential to prevent more serious damage resulting in hemorrhages in alveoli.
UNLABELLED: Essentials Role of platelets in immunological transfusion-related acute lung injury (TRALI) is debated. Immunological TRALI was tested in mice exhibiting severe thrombocytopenia or platelet dysfunction. Platelets are required to prevent lung hemorrhage but not edema formation and respiratory distress. Platelets are dispensable for the initiation and development of TRALI. SUMMARY: Background Transfusion-related acute lung injury (TRALI) is a serious transfusion-related complication. Previous conflicting studies have indicated that platelets are either crucial or dispensable for TRALI. Objectives To evaluate the role of platelets in major histocompatibility complex (MHC) I-induced-TRALI. Methods Antibody-mediated TRALI was experimentally induced in mice by lipopolysaccharide priming followed by the administration of an anti-MHC I mAb. Results TRALI was tested in the context of severe thrombocytopenia provoked by the administration of diphtheria toxin (DT) in transgenic iDTR mice selectively expressing DT receptor in megakaryocytes. The pathologic responses occurring within the first 10 min following the injection of the anti-MHC I mAb, i.e. the severity of lung edema and the drop in aortic blood oxygenation, were similar in severely thrombocytopenicDT-iDTR and control mice. At later times, mortality was nevertheless increased in DT-iDTRmice, owing to lung hemorrhages. When less severe thrombocytopenia was induced with an antiplatelet mAb, TRALI started and developed similarly as in control mice, but hemorrhages were absent. Furthermore, when platelet functions were defective because of administration of aspirin or clopidogrel, or because of glycoprotein (GP)IIbIIIa deficiency, TRALI still developed but no lung hemorrhages were observed. In contrast, when GPVI was immunodepleted, TRALI still occurred, but was occasionally accompanied by hemorrhages. Conclusions Platelets are dispensable for the initiation and development of MHC I-induced TRALI. Although they do not protect against the disruption of the vascular endothelial cell barrier and the subsequent plasma leakage and edema formation, platelets are essential to prevent more serious damage resulting in hemorrhages in alveoli.
Authors: Rick Kapur; Michael Kim; Rukhsana Aslam; Mark J McVey; Arata Tabuchi; Alice Luo; Jonathan Liu; Yuan Li; Shanjeevan Shanmugabhavananthan; Edwin R Speck; Anne Zufferey; George Yousef; Haibo Zhang; Matthew T Rondina; Andrew S Weyrich; Leendert Porcelijn; Wolfgang M Kuebler; Arthur S Slutsky; John W Semple Journal: Blood Date: 2017-02-15 Impact factor: 22.113
Authors: Elizabeth A Middleton; Matthew T Rondina; Hansjorg Schwertz; Guy A Zimmerman Journal: Am J Respir Cell Mol Biol Date: 2018-07 Impact factor: 6.914
Authors: Eveline A N Zeeuw van der Laan; Saskia van der Velden; Arthur E H Bentlage; Mads D Larsen; Thijs L J van Osch; Juk Yee Mok; Giso Brasser; Dionne M Geerdes; Carolien A M Koeleman; Jan Nouta; John W Semple; Leendert Porcelijn; Wim J E van Esch; Manfred Wuhrer; C Ellen van der Schoot; Gestur Vidarsson; Rick Kapur Journal: Blood Adv Date: 2020-08-25
Authors: Siân Lax; Julie Rayes; Surasak Wichaiyo; Elizabeth J Haining; Kate Lowe; Beata Grygielska; Ryan Laloo; Per Flodby; Zea Borok; Edward D Crandall; David R Thickett; Steve P Watson Journal: Am J Physiol Lung Cell Mol Physiol Date: 2017-08-24 Impact factor: 5.464
Authors: Michaela Finsterbusch; Waltraud C Schrottmaier; Julia B Kral-Pointner; Manuel Salzmann; Alice Assinger Journal: Platelets Date: 2018-02-20 Impact factor: 3.862
Authors: Marie-Belle El Mdawar; Blandine Maître; Stéphanie Magnenat; Christian Gachet; Béatrice Hechler; Henri de la Salle Journal: Sci Rep Date: 2019-03-26 Impact factor: 4.379
Authors: Marie-Belle El Mdawar; Blandine Maître; Stéphanie Magnenat; Florian Tupin; Friederike Jönsson; Christian Gachet; Henri de la Salle; Beatrice Hechler Journal: Blood Adv Date: 2021-12-14
Authors: Ilse Jongerius; Leendert Porcelijn; Anna E van Beek; John W Semple; C Ellen van der Schoot; Alexander P J Vlaar; Rick Kapur Journal: Transfus Med Rev Date: 2019-10-18
Authors: Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski Journal: Biomedicines Date: 2022-01-04
Authors: Simon J Cleary; Nicholas Kwaan; Jennifer J Tian; Daniel R Calabrese; Beñat Mallavia; Mélia Magnen; John R Greenland; Anatoly Urisman; Jonathan P Singer; Steven R Hays; Jasleen Kukreja; Ariel M Hay; Heather L Howie; Pearl Toy; Clifford A Lowell; Craig N Morrell; James C Zimring; Mark R Looney Journal: J Clin Invest Date: 2020-11-02 Impact factor: 14.808